Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)
Similar Posts
BlendHouse LLC. Reading, PA. 483 issued 01/19/2024
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 01/19/2024
Short Title (70 char) BlendHouse LLC. Reading, PA. 483 issued 01/19/2024
FEI Number 3015728839
Firm Name BlendHouse LLC
Record Type 483
State PA
Establishment Type ManufacturerActivities Report of the Generic Drug Program (FY 2025) – FDARA Title VIII Sections 807 and 805
Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug applications (ANDAs).Mobile Power Unit AC Power Cord Recall: Abbott Medical Removes AC Power Cord Associated with HeartMate Mobile Power Unit (MPU) Due to Potential Risk of the Cord Not Locking into Place
Abbott Medical is removing power cords associated with the HeartMate Mobile Power Unit due to a potential risk of the cord not locking into place.iPLEDGE Risk Evaluation and Mitigation Strategy (REMS)
The goal of the iPLEDGE REMS is to mitigate the risk of embryo-fetal toxicity.Alert: Automated Impella Controller Correction due to Cybersecurity Issue from Abiomed
Abiomed has issued a letter to affected customers of cybersecurity vulnerabilities related to the operating system in the Automated Impella Controller